Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · January 11, 2018

Auto-CD34+ Cell Therapy Improves Exercise Capacity, Angina Frequency, and Reduces Mortality in Refractory Angina

European Heart Journal


Additional Info

Disclosure statements are available on the authors' profiles:

European Heart Journal
Autologous CD34+ Cell Therapy Improves Exercise Capacity, Angina Frequency and Reduces Mortality in No-Option Refractory Angina: A Patient-Level Pooled Analysis of Randomized Double-Blinded Trials
Eur Heart J 2018 Jan 05;[EPub Ahead of Print], TD Henry, DW Losordo, JH Traverse, RA Schatz, EM Jolicoeur, GL Schaer, R Clare, K Chiswell, CJ White, FD Fortuin, DJ Kereiakes, AM Zeiher, W Sherman, AS Hunt, TJ Povsic

Further Reading